JP2010501160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501160A5 JP2010501160A5 JP2009524009A JP2009524009A JP2010501160A5 JP 2010501160 A5 JP2010501160 A5 JP 2010501160A5 JP 2009524009 A JP2009524009 A JP 2009524009A JP 2009524009 A JP2009524009 A JP 2009524009A JP 2010501160 A5 JP2010501160 A5 JP 2010501160A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- item
- cell
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83720906P | 2006-08-11 | 2006-08-11 | |
| US60/837,209 | 2006-08-11 | ||
| US11/836,645 US7972602B2 (en) | 2006-08-11 | 2007-08-09 | Promiscuous HER-2/Neu CD4 T cell epitopes |
| US11/836,645 | 2007-08-09 | ||
| PCT/US2007/075681 WO2008022019A2 (en) | 2006-08-11 | 2007-08-10 | Promiscuous her-2/neu cd4 t cell epitopes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010501160A JP2010501160A (ja) | 2010-01-21 |
| JP2010501160A5 true JP2010501160A5 (https=) | 2011-09-08 |
| JP5189593B2 JP5189593B2 (ja) | 2013-04-24 |
Family
ID=39082993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009524009A Expired - Fee Related JP5189593B2 (ja) | 2006-08-11 | 2007-08-10 | 無差別ＨＥＲ−２／ＮｅｕＣＤ４Ｔ細胞エピトープ |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7972602B2 (https=) |
| EP (2) | EP2570422B1 (https=) |
| JP (1) | JP5189593B2 (https=) |
| CA (1) | CA2660178C (https=) |
| ES (2) | ES2441252T3 (https=) |
| HU (1) | HUE026977T2 (https=) |
| PL (1) | PL2570422T3 (https=) |
| WO (1) | WO2008022019A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017096247A1 (en) * | 2015-12-04 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Methods and vaccines for inducing immune responses to multiple different mhc molecules |
| US12247053B2 (en) | 2018-10-26 | 2025-03-11 | Saint Louis University | Peptides for inducing heterosubtypic influenza T cell responses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4673641A (en) | 1982-12-16 | 1987-06-16 | Molecular Genetics Research And Development Limited Partnership | Co-aggregate purification of proteins |
| US5552534A (en) | 1991-08-22 | 1996-09-03 | The Trustees Of The University Of Pennsylvania | Non-Peptide peptidomimetics |
| US5550251A (en) | 1991-12-12 | 1996-08-27 | The Trustees Of The University Of Pennsylvania | Alicyclic peptidomimetics |
| US5801005A (en) * | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| US6160089A (en) | 1998-07-08 | 2000-12-12 | Mitsui Chemicals, Inc. | Method for secretory production of human growth hormone |
| US7060284B1 (en) * | 1999-08-03 | 2006-06-13 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| AU2087401A (en) | 1999-12-10 | 2001-06-18 | Epimmune, Inc. | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| WO2001074855A2 (en) * | 2000-03-30 | 2001-10-11 | Dendreon Corporation | Compositions and methods for dendritic cell-based immunotherapy |
| US20040121946A9 (en) * | 2000-12-11 | 2004-06-24 | John Fikes | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| WO2005007694A1 (ja) * | 2003-07-16 | 2005-01-27 | Green Peptide Co., Ltd. | ＨＥＲ２／ｎｅｕペプチドおよびその治療上の用途 |
| GB0427131D0 (en) * | 2004-12-10 | 2005-01-12 | Glaxosmithkline Biolog Sa | Novel combination |
-
2007
- 2007-08-09 US US11/836,645 patent/US7972602B2/en active Active
- 2007-08-10 PL PL12168585.3T patent/PL2570422T3/pl unknown
- 2007-08-10 CA CA2660178A patent/CA2660178C/en active Active
- 2007-08-10 WO PCT/US2007/075681 patent/WO2008022019A2/en not_active Ceased
- 2007-08-10 EP EP12168585.3A patent/EP2570422B1/en active Active
- 2007-08-10 EP EP07813984.7A patent/EP2054430B1/en active Active
- 2007-08-10 HU HUE12168585A patent/HUE026977T2/en unknown
- 2007-08-10 ES ES07813984.7T patent/ES2441252T3/es active Active
- 2007-08-10 ES ES12168585.3T patent/ES2561677T3/es active Active
- 2007-08-10 JP JP2009524009A patent/JP5189593B2/ja not_active Expired - Fee Related
-
2011
- 2011-05-31 US US13/149,408 patent/US8263757B2/en active Active
-
2012
- 2012-08-16 US US13/587,619 patent/US8658177B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7212198B2 (ja) | Ｒｓｖ ｆタンパク質突然変異体 | |
| CA2621414C (en) | Mmp-7 and adf derived tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules | |
| JP2009506762A5 (https=) | ||
| JP2010500037A5 (https=) | ||
| JP2013517783A5 (https=) | ||
| JP2012510431A5 (https=) | ||
| JP2019510465A5 (https=) | ||
| JP2018511321A5 (https=) | ||
| JP2018529320A5 (https=) | ||
| EP1239866A1 (en) | INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS | |
| WO2008039818A3 (en) | Modified t cell receptors and related materials and methods | |
| JP2015506705A5 (https=) | ||
| JP2022513019A (ja) | 新規の酸化還元酵素モチーフを有する免疫原性ペプチド | |
| JP2012517799A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| CA2962933A1 (en) | Use of hla genetic status to assess or select treatment of celiac disease | |
| JP2011522777A5 (https=) | ||
| JP2013523084A5 (https=) | ||
| JP2015529219A5 (https=) | ||
| JP2013517764A5 (https=) | ||
| JP2010501160A5 (https=) | ||
| JP2012526519A5 (https=) | ||
| Yazdanian et al. | Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c mice | |
| Reimann et al. | DNA vaccines expressing antigens with a stress protein‐capturing domain display enhanced immunogenicity | |
| JP2013513549A5 (https=) |